Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic status and insulin resistance
- PDF / 458,063 Bytes
- 4 Pages / 595.276 x 790.866 pts Page_size
- 67 Downloads / 232 Views
ORIGINAL ARTICLE
Pulmonary function tests in type 2 diabetes mellitus and their association with glycemic status and insulin resistance Sarita Bajaj 1 & Sparsh Anil 1 & Rajpal Prajapati 1 Received: 27 May 2019 / Accepted: 12 January 2020 # Research Society for Study of Diabetes in India 2020
Abstract Introduction Type 2 diabetes mellitus (T2DM) is associated with long-term complications in different organs, and this is attributable to macrovascular and microvascular changes as reported by Fowler. Pulmonary complications, however, have been poorly characterised. Materials and methods The present study was a case–control study done at SRN Hospital, Prayagraj to correlate the pulmonary functions with glycemic status and insulin resistance in 100 patients with diabetes (cases) and compare these parameters in patients without diabetes (controls). Baseline values of fasting plasma glucose (FPG), prandial plasma glucose (PPG) and glycated hemoglobin (A1C) were significantly increased in cases as compared with controls. Results Forced expiratory volume (FEV1) (78.71% compared with 88.15%) and forced vital capacity (FVC) (67.48% compared with 96.58%) were both decreased in cases compared with controls but as decline in FVC was more compared with FEV1; their ratio, FEV1/FVC (121.70 as compared to 90.19), was increased in cases. FVC decreased with increase in A1C values (96.2%, 84.2%, 71.2% for A1C values 5.7%, 5.7–6.4% and > 6.4% respectively). FVC was also decreased for greater values of Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) (98.2% for HOMA-IR < 2.5 and 74.6% for HOMA-IR > 2.5). The ratio of FEV1/FVC was more with higher values of A1C (103.3 for A1C > 2.5 and 91.1 for A1C < 2.5). FVC also decreased with increasing values of FPG (97.4%, 91.1% and 71.2% for FPG values of < 100 mg%, 100–125 mg% and ≥ 126 mg%). Conclusion A total of 65% of patients had abnormal pulmonary function tests with predominance of restrictive pattern. This restrictive decline is significantly associated with increasing dysglycemia and insulin resistance. However, it is unrelated to levels of low-density lipoprotein (LDL) and duration of T2DM. Keywords Type 2 diabetes mellitus . Insulin resistance . Pulmonary function tests . Forced vital capacity
Introduction Reduced pulmonary functions have been seen in patients with diabetes [2]. Pulmonary diseases are broadly classified as obstructive and restrictive based on the pulmonary function tests (PFTs). Diabetes causes pulmonary complications by microangiopathy of the alveolar capillary network. Impairment in * Sarita Bajaj [email protected] Sparsh Anil [email protected] Rajpal Prajapati [email protected] 1
Department of Medicine, MLN Medical College, Prayagraj, India
lung function of patients with diabetes is believed to be the consequences of biochemical alterations in the connective tissue constituents of the lung, particularly collagen and elastin, as well as microangiopathy due to the nonenzymatic glycosylation of proteins induced by chronic hyper
Data Loading...
